Renal Resistance Index in Renal Allograft Recipients: A Role for ADMA

American Journal of Kidney Diseases

Volumn 54, Issue 2, 2009, Pages 327-333

  Bergmann, Ivo P ^a   Böger, Rainer H ^b   Marti, Elizabeth ^a   Frey, Felix J ^a   Schwedhelm, Edzard ^b   Eisenberger, Ute ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

allograft function; Asymmetric dimethylarginine; cardiovascular risk factors; pulse pressure; renal resistance index; renal transplantation; ultrasound

Indexed keywords

N(G),N(G) DIMETHYLARGININE;

ADULT; AGED; ARTERIAL STIFFNESS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PULSE PRESSURE; RECIPIENT; RENAL RESISTANCE INDEX; TANDEM MASS SPECTROMETRY;

ADULT; AGED; ARGININE; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RENAL ARTERY; VASCULAR RESISTANCE; YOUNG ADULT;

EID: 67650487561     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.04.028     Document Type: Article

References (28)

1. Radermacher J., Mengel M., Ellis S., et al. The renal arterial resistance index and renal allograft survival. N Engl J Med 349 (2003) 115-124
2. Schwenger V., Keller T., Hofmann N., et al. Color Doppler indices of renal allografts depend on vascular stiffness of the transplant recipients. Am J Transplant 6 (2006) 2721-2724
3. Heine G.H., Gerhart M.K., Ulrich C., Kohler H., and Girndt M. Renal Doppler resistance indices are associated with systemic atherosclerosis in kidney transplant recipients. Kidney Int 68 (2005) 878-885
4. Vallance P., Leone A., Calver A., Collier J., and Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339 (1992) 572-575
5. Boger R.H. Asymmetric dimethylarginine (ADMA): A novel risk marker in cardiovascular medicine and beyond. Ann Med 38 (2006) 126-136
6. Zoccali C., Bode-Boger S., Mallamaci F., et al. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study. Lancet 358 (2001) 2113-2117
7. Kielstein J.T., Boger R.H., Bode-Boger S.M., et al. Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease. J Am Soc Nephrol 13 (2002) 170-176
8. Cooke J.P. ADMA: Its role in vascular disease. Vasc Med 10 suppl 1 (2005) S11-S17
9. Fliser D., Kronenberg F., Kielstein J.T., et al. Asymmetric dimethylarginine and progression of chronic kidney disease: The mild to moderate kidney disease study. J Am Soc Nephrol 16 (2005) 2456-2461
10. Yilmaz M.I., Saglam M., Caglar K., et al. Endothelial functions improve with decrease in asymmetric dimethylarginine (ADMA) levels after renal transplantation. Transplantation 80 (2005) 1660-1666
11. Nankivell B.J., Gruenewald S.M., Allen R.D., and Chapman J.R. Predicting glomerular filtration rate after kidney transplantation. Transplantation 59 (1995) 1683-1689
12. Schwedhelm E., Tan-Andresen J., Maas R., Riederer U., Schulze F., and Boger R.H. Liquid chromatography-tandem mass spectrometry method for the analysis of asymmetric dimethylarginine in human plasma. Clin Chem 51 (2005) 1268-1271
13. Schwedhelm E., Maas R., Tan-Andresen J., Schulze F., Riederer U., and Boger R.H. High-throughput liquid chromatographic-tandem mass spectrometric determination of arginine and dimethylated arginine derivatives in human and mouse plasma. J Chromatogr 851 (2007) 211-219
14. D'Agostino Sr. R.B., Grundy S., Sullivan L.M., and Wilson P. Validation of the Framingham coronary heart disease prediction scores: Results of a multiple ethnic groups investigation. JAMA 286 (2001) 180-187
15. Sollinger D., Mohaupt M.G., Wilhelm A., Uehlinger D., Frey F.J., and Eisenberger U. Arterial stiffness assessed by digital volume pulse correlates with comorbidity in patients with ESRD. Am J Kidney Dis 48 (2006) 456-463
16. Tublin M.E., Bude R.O., and Platt J.F. Review. The resistive index in renal Doppler sonography: Where do we stand?. AJR Am J Roentgenol 180 (2003) 885-892
17. Pontremoli R., Viazzi F., Martinoli C., et al. Increased renal resistive index in patients with essential hypertension: A marker of target organ damage. Nephrol Dial Transplant 14 (1999) 360-365
18. Ohta Y., Fujii K., Arima H., et al. Increased renal resistive index in atherosclerosis and diabetic nephropathy assessed by Doppler sonography. J Hypertens 23 (2005) 1905-1911
19. Heine G.H., Reichart B., Ulrich C., Kohler H., and Girndt M. Do ultrasound renal resistance indices reflect systemic rather than renal vascular damage in chronic kidney disease?. Nephrol Dial Transplant 22 (2007) 163-170
20. Weber T., Maas R., Auer J., et al. Arterial wave reflections and determinants of endothelial function: A hypothesis based on peripheral mode of action. Am J Hypertens 20 (2007) 256-262
21. Kielstein J.T., Simmel S., Bode-Boger S.M., et al. Subpressor dose asymmetric dimethylarginine modulates renal function in humans through nitric oxide synthase inhibition. Kidney Blood Press Res 27 (2004) 143-147
22. Kielstein J.T., Salpeter S.R., Bode-Boeger S.M., Cooke J.P., and Fliser D. Symmetric dimethylarginine (SDMA) as endogenous marker of renal function-A meta-analysis. Nephrol Dial Transplant 21 (2006) 2446-2451
23. Busch M., Fleck C., Wolf G., and Stein G. Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease-Possible candidates for paradoxical epidemiology?. Amino Acids 30 (2006) 225-232
24. Leiper J.M., Santa Maria J., Chubb A., et al. Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases. Biochem J 343 (1999) 209-214
25. Tojo A., Kimoto M., and Wilcox C.S. Renal expression of constitutive NOS and DDAH: Separate effects of salt intake and angiotensin. Kidney Int 58 (2000) 2075-2083
26. Nijveldt R.J., Van Leeuwen P.A., Van Guldener C., Stehouwer C.D., Rauwerda J.A., and Teerlink T. Net renal extraction of asymmetrical (ADMA) and symmetrical (SDMA) dimethylarginine in fasting humans. Nephrol Dial Transplant 17 (2002) 1999-2002
27. Matsumoto Y., Ueda S., Yamagishi S., et al. Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease. J Am Soc Nephrol 18 (2007) 1525-1533
28. Tanaka M., Sydow K., Gunawan F., et al. Dimethylarginine dimethylaminohydrolase overexpression suppresses graft coronary artery disease. Circulation 112 (2005) 1549-1556